Evidence map›Paper›PMID 30734696›Full record

ArticleThe American journal of tropical medicine and hygiene2020

Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial.

Assaf P Oron, Roy Burstein, Laina D Mercer, Ahmed M Arzika, Khumbo Kalua, Zakayo Mrango, Sheila K West, Robin L Bailey, Travis C Porco, Thomas M Lietman

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution.The American journal of tropical medicine and hygiene · 2020
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Assaf P OronInstitute for Disease Modeling, Bellevue, Washington.
Roy BursteinInstitute for Health Metrics and Evaluation, University of Washington, Seattle, Washington.
Laina D MercerInstitute for Disease Modeling, Bellevue, Washington.
Ahmed M ArzikaThe Carter Center, Niamey, Niger.
Khumbo KaluaBlantyre Institute for Community Outreach and the College of Medicine, University of Malawi, Blantyre.
Zakayo MrangoNational Institute for Medical Research, Dar es Salaam, Tanzania.
Sheila K WestThe Dana Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Robin L BaileyThe London School of Tropical Hygiene and Medicine, London, United Kingdom.
Travis C PorcoDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California.
Thomas M LietmanDepartment of Ophthalmology, University of California, San Francisco, San Francisco, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined whether baseline mortality risk, as a function of child age and site, modified the azithromycin mortality-reduction effect in the

Indexed as

Child MortalityAnti-Bacterial AgentsAzithromycinChildClinical Trials as TopicHumansMacrolidesProportional Hazards ModelsAnti-Bacterial AgentsAzithromycinMacrolides

Identifiers

PMID30734696
PMCPMC7470539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.